Temporarily Stop One Batch AstraZeneca
The government temporarily suspended the distribution and use of the AstraZeneca vaccine batch (production batch) coded CTMAV547.
The Food and Drug Supervisory Agency (BPOM) will test the toxicity and sterility of this vaccine. "This is a precautionary measure by the government to ensure the safety of this vaccine," said the Ministry of Health's vaccination spokeswoman, Siti Nadia Tarmizi, yesterday. He added, all AstraZeneca batch vaccines outside of CTMAV547 can be used and continue to be distributed to the public. Toxicity is the property of a substance to cause damage when exposed to an organism's structure, such as a cell or organ. Meanwhile, sterility is tested to determine whether the vaccine given is clean from germs or other micro-organisms. The cessation of the use of the AstraZeneca vaccine with the code CTMAV547 was forgotten after reports of the death of Trio Fauqi Virdaus, a resident of Buaran, Duren Sawit, East Jakarta. The trio were said to have had a fever after receiving the vaccine on May 6. His condition was brought and still had a fever, then he went to the hospital. However, after being treated for a while, Trio was declared dead at around 12.30 WIB. The National Commission for Post-Immunization Adverse Events (KIPI) wrote to BPOM regarding the Trio incident on 10 May. Komnas KIPI stated that it had not received enough evidence for the death of the young man from Jakarta with the Covid-19 vaccination. Based on Komnas KIPI data, to date, there has never been an incident of people dying from the Covid-19 vaccination in Indonesia.
|•SOURCE•| Image :LINE TODAY |
READ MORE
|• NATIONAL •|Strengthening Logistics, Minister of Transportation Asks the Private Sector to Play a Role in Building Ports
|• INTERNATIONAL •|Trade Performance 2022, Surplus Shocks Mitigated
|• BANKING •|Government Needs to Consider Direct Subsidy for Cooking Oil
|• POLITICS •|Stop Coal, INDONESIA's New Renewable Energy Mix Target in 2025 Still Minus 11.5 Percent
|• SCIENCE •|The Minister of Trade Reveals the Attractiveness of Investment in Indonesia
0 comments: